Filing Details
- Accession Number:
- 0000914190-16-000832
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-09-12 17:27:26
- Reporting Period:
- 2016-09-08
- Filing Date:
- 2016-09-12
- Accepted Time:
- 2016-09-12 17:27:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 842023 | Bio-Techne Corp | TECH | Biological Products, (No Disgnostic Substances) (2836) | 411427402 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1662638 | S Kevin Gould | 2948 Wauneta Street Newbury Park CA 91320 | Svp Clinical Controls | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2016-09-08 | 524 | $110.50 | 1,667 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to Buy) | $97.23 | 2022-07-09 | 50,000 | 50,000 | Direct | |
| Common Stock | Stock Options (Right to Buy) | $97.23 | 2022-07-09 | 15,000 | 15,000 | Direct | |
| Common Stock | Stock Options (Right to Buy) | $88.23 | 2023-01-04 | 10,000 | 10,000 | Direct | |
| Common Stock | Stock Options (Right to Buy) | $106.59 | 2023-08-18 | 17,371 | 17,371 | Direct | |
| Common Stock | Stock Options (Right to Buy) | $106.59 | 2023-08-18 | 13,028 | 13,028 | Direct | |
| Common Stock | Restricted Stock Units | $0.00 | 2,111 | 2,111 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2022-07-09 | 50,000 | 50,000 | Direct |
| 2022-07-09 | 15,000 | 15,000 | Direct |
| 2023-01-04 | 10,000 | 10,000 | Direct |
| 2023-08-18 | 17,371 | 17,371 | Direct |
| 2023-08-18 | 13,028 | 13,028 | Direct |
| 2,111 | 2,111 | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.4934 to $110.5402 inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- Includes 833 shares of restricted stock units that vest on 7/9/17 and 834 shares of restricted stock units that vest on 7/9/18.
- 50,000 common stock options vest if certain performance goals are achieved for the 12 months ending 05/31/18.
- Vests as to 2,500 shares on each of 01/04/17, 01/04/18, 01/04/19 and 01/04/20.
- Vests 4,343 shares on each of 8/18/17, 8/18/18 and 8/18/19, and 4,342 shares on 8/18/20.
- Vests in full or in part on 8/18/19 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
Billionaire Hedge Funds
